camonsertib,Niraparib,Olaparib,Talazoparib
repare therapeutics,roche,gsk,astrazeneca,merck,pfizer
['tresr', 'camonsertib', 'bridge bio', 'repare therap', 'repare,(-prepare)']
bcbn feed: repare therapeutics presents initial clinical data from the phase 1/2 tresr and attacc trials evaluating camonsertib in combination with three parp inhibitors at the 2023 aacr annual meeting: ... #boston #biotech 
Boston Cambridge Biotech Networks: Building a community and providing news and events for the local life science industry. For jobs follow @bcbnjobs